Novartis reports new Phase III data showing omalizumab significantly...
http://www.pharmalive.com/novartis-omalizumab-meets-phase-iii-endpoints
Tracks information on drugs on worldwide basis by Dr Anthony Melvin Crasto, helping millions with websites, 9 million hits on google, 2.5 lakh connections worldwide, P.S. : The views expressed are my personal and in no-way suggest the views of the professional body or the company that I represent.
No comments:
Post a Comment